pharma · Anemia · Anemia Associated With Chronic Kidney Disease · AKBA
Akebia Europe
Akebia Europe Limited
Akebia Europe trial registry — 42 ClinicalTrials.gov studies with program phase, status, and indication context.
Cambridge, USA HQ
2007 Founded
271 Employees
Public company Type
AKBA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2007
- Employees
- 271
- Programs
- 25
- Drugs
- 13
- Patents
- 28
Akebia Europe clinical trials
Registry index of 42 ClinicalTrials.gov studies linked to Akebia Europe programs — each row shows trial ID, program name, phase, status, and indication.
Akebia Europe trial registry — 42 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Akebia Europe.
-
AKB-6548-CI-0013 — Phase 1
Clinical update -
vadadustat reference tablets — Phase 1
Clinical update -
Ferric Citrate 1 gram Oral Tablet — Approved
Clinical update -
Ferric Citrate 1 GM Oral Tablet [AURYXIA] — Phase 3
Clinical update -
Epoetin alga (Epogen)/vadadustat — Phase 3
Clinical update -
Erythropoiesis-Stimulating Agent (ESA) — Phase 3
Clinical update -
AKB-6548 (therapeutic dose) — Phase 1
Clinical update -
Vadadustat — Phase 3
Clinical update
Trial registry
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗